Investment climate improves in US, says Burrill
This article was originally published in Clinica
Executive Summary
At the same time Burrill & Co, a US merchant bank which invests solely in the life sciences sector, has noted a massive 63% increase in the volume of capital raised by the biotech industry in the second quarter. The industry's level of IPOs still remained below that of the same period last year, but venture capital and convertible debt brought into the industry totalled $1.4 billion.